Early but not serial ustekinumab concentration measurements are associated with clinical outcomes in Crohn&#39;s disease and ulcerative colitis: the Stockholm Ustekinumab study (STOCUSTE).

Stelara (ustekinumab) - J&J

http://www.ncbi.nlm.nih.gov/pubmed/42765296

Alexandra Borin; Charlotte Höög; Charlotte Söderman; Christina Wennerström; Francesca Bello; Fredrik Johansson; Haider Sabhan; Mikael Lördal; Ole Forsberg; Samer Muhsen; Sven Almer

Sep 22, 2026